For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
HomeSystematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over
Publication metadata
Seasonal influenza is an infectious respiratory disease which circulates annually and is associated with a considerable health and economic burden globally. The most effective means of preventing seasonal influenza is through strain-specific vaccination. For many decades, only trivalent influenza vaccines (that include two influenza A strains and one influenza B strain) have been available. In recent years, quadrivalent (two influenza A strains and two influenza B strains) have been authorised and are increasingly available. Traditional influenza vaccines have limitations in terms of immune response and the substrate used in their manufacturing which can reduce overall effectiveness. Newer and enhanced influenza vaccines have been developed, both in trivalent and quadrivalent forms, in an attempt to counteract these limitations.
- Published:
- Corporate author(s): European Centre for Disease Prevention and Control (EU body or agency)
- Themes: Health policy , Medical and biological research
- Subject: clinical trial , infectious disease , medical research , research report , vaccine
|
PDF
|
|||
| ISSN | ISBN 978-92-9498-467-8 | DOI 10.2900/751620 | Catalogue number TQ-02-20-772-EN-N |
- Released on EU publications website:
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages